Bavarian Nordic CEO sees massive sales potential for Covid-19 vaccine after securing state aid
If the company manages to produce a Covid-19 vaccine, the sales potential will be huge, says CEO Paul Chaplin, who is happy about the recent aid agreement reached with the Danish government.
BY SIGNE FERSLEV PEDERSEN & LEONORA BECK, TRANSLATED BY CATHERINE BRETT
Bavarian Nordic CEO Paul Chaplin predicts huge growth potential for its Covid-19 vaccine, as a EUR 108m financial support agreement with the Danish government fell into place on Monday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
